http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-41488-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-451
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02
filingDate 1975-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1980-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber IE-41488-B1
titleOfInvention D and 1-cyanocyproheptadine compositions containing it and methods of using it
abstract (-)-1-Methyl-4-(3-cyano-5H-dibenzo[a,d]cyclohepten-5-ylidene)piperi dine and (+)-1-methyl-4-(3-cyano-5H-dibenzo[a,d]cyclohepten-5-ylidene)piperidin e are prepared in virtually pure form. These compounds are obtained by preparing the diastereomeric salts of the corresponding (+/-)-racemate in suitable solvents using optically active acids. The (-)-form, which is virtually free of the (+)-form, is then removed by crystallisation. The salt obtained is then converted into the free base, and the (+)-form is isolated from the residue as the free base. The (+)-form of the base and also the corresponding acid addition salts can be used as peripheral and central anticholinergics. The (-)-form of the base including corresponding acid addition salts can be used as sedatives.
priorityDate 1974-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448525428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507434
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2724144
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420274578
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453918403
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3559
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15165712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21696466

Total number of triples: 24.